- US-listed companies
- Regenicin, Inc.
- Income statement
Regenicin, Inc.【RGIN】Income statement
Market cap
$15.35K
P/E ratio
| 2011/09 | 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | |
| Research & development | 518,902 | 1 | 2 | - | 38,401 | 1,445 | 5,284 | - | - | - | - |
| Operating expenses | 4 | 7 | 11 | 725,895 | 241,823 | 1 | 976,108 | 789,105 | 736,553 | 663,749 | 842,364 |
| Operating income | -3,658,707 | -2,358,939 | -3,997,763 | -725,895 | -241,823 | -779,854 | -961,108 | -540,277 | -736,553 | -510,816 | -842,364 |
| Income before tax | - | - | - | -688,878 | 3 | -1,089,902 | - | - | - | - | - |
| Provision for income taxes | - | - | - | 3 | 3 | - | - | - | - | - | - |
| Effective tax rate (%) | - | - | - | - | - | - | - | - | - | ||
| Net income | -3,665,582 | - | - | 2 | 242,599 | -1,089,902 | 973,937 | -559,058 | 758,456 | 559,591 | -877,102 |